Ceramide Kinase Inhibitor that Improves Intracellular Lipid Transport Disorders
Cyclic pyrrole-imidazole polyamide (cPIP) selectively suppresses expression of pathogenic RNA in CAG/CTG triplet repeat neurological diseases.
New chemical entities promoting degradation of ubiquitinated protein aggregates through induction of selective autophagy
Combination of microglia activation inhibitor and TNF blocker improve neuronopathic symptoms
Original method and hepatocyte reproduced hepatobiliary function